Selective portal vein injection for the design of syngeneic models of liver malignancy

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 310, Issue 9, 2016, Pages G682-G688

  Limani, Perparim ^a   Borgeaud, Nathalie ^a   Linecker, Michael ^a   Tschuor, Christoph ^a   Kachaylo, Ekaterina ^a   Schlegel, Andrea ^a   Jang, Jae Hwi ^a   Ungethüm, Udo ^a   Montani, Matteo ^b   Graf, Rolf ^a   Humar, Bostjan ^a   Clavien, Pierre Alain ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

Colorectal cancer; Fibrosis; Hepatocellular carcinoma; Metastasis; Murine model of liver cancer

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CANCER CELL; CELL AGGREGATION; CONTROLLED STUDY; FLOW CYTOMETRY; LIVER CELL; LIVER CELL CARCINOMA; LIVER LOBE; LIVER TUMOR; MALE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PORTAL VEIN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR GROWTH; TUMOR MODEL; ANIMAL; BAGG ALBINO MOUSE; C57BL MOUSE; CANCER TRANSPLANTATION; CELL LINE; DIAGNOSTIC IMAGING; DISEASE MODEL; HEPATIC PORTAL VEIN; INTRAVENOUS DRUG ADMINISTRATION; LIVER NEOPLASMS; PATHOLOGY; PROCEDURES; TUMOR CELL LINE;

ANIMALS; CELL LINE; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; INJECTIONS, INTRAVENOUS; LIVER NEOPLASMS; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; NEOPLASM TRANSPLANTATION; PORTAL VEIN;

EID: 84984596159     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.00209.2015     Document Type: Article

References (18)

1. Bousserouel S, Bour G, Kauntz H, Gosse F, Marescaux J, Raul F. Silibinin inhibits tumor growth in a murine orthotopic hepatocarcinoma model and activates the TRAIL apoptotic signaling pathway. Anticancer Res 32: 2455–2462, 2012.
2. Clavien PA, Petrowsky H, DeOliveira ML, Graf R. Strategies for safer liver surgery and partial liver transplantation. New Engl J Med 356: 1545–1559, 2007.
3. Corbett TH, Griswold DP Jr, Roberts BJ, Peckham JC, Schabel FM Jr. Tumor induction relationships in development of transplantable cancers of the colon in mice for chemotherapy assays, with a note on carcinogen structure. Cancer Res 35: 2434–2439, 1975.
4. Darlington GJ, Bernhard HP, Miller RA, Ruddle FH. Expression of liver phenotypes in cultured mouse hepatoma cells. J Natl Cancer Inst 64: 809–819, 1980.
5. Endo T, Toda M, Watanabe M, Iizuka Y, Kubota T, Kitajima M, Kawakami Y. In situ cancer vaccination with a replication-conditional HSV for the treatment of liver metastasis of colon cancer. Cancer Gene Ther 9: 142–148, 2002.
6. Fleet JC. Animal models of gastrointestinal and liver diseases. New mouse models for studying dietary prevention of colorectal cancer. Am J Physiol Gastrointest Liver Physiol 307: G249–G259, 2014.
7. Funahashi Y, Koyanagi N, Sonoda J, Kitoh K, Yoshimatsu K. Rapid development of hepatic metastasis with high incidence following orthotopic transplantation of murine colon 38 carcinoma as intact tissue in syngeneic C57BL/6 mice. J Surg Oncol 71: 83–90, 1999.
8. Georges C, Lo T, Alkofer B, Whelan R, Allendorf J. The effects of surgical trauma on colorectal liver metastasis. Surg Endosc 21: 1817–1819, 2007.
9. Griswold DP, Corbett TH. A colon tumor model for anticancer agent evaluation. Cancer 36: 2441–2444, 1975.
10. Heinrich S, Jochum W, Graf R, Clavien PA. Portal vein ligation and partial hepatectomy differentially influence growth of intrahepatic metastasis and liver regeneration in mice. J Hepatol 45: 35–42, 2006.
11. Melloul E, Raptis DA, Boss A, Pfammater T, Tschuor C, Tian Y, Graf R, Clavien PA, Lesurtel M. Small animal magnetic resonance imaging: an efficient tool to assess liver volume and intrahepatic vascular anatomy. J Surg Res 187: 458–465, 2014.
12. Orlowski K, Rohrer Bley C, Zimmermann M, Vuong V, Hug D, Soltermann A, Broggini-Tenzer A, Pruschy M. Dynamics of tumor hypoxia in response to patupilone and ionizing radiation. PLoS One 7: e51476, 2012.
13. Patek PQ, Collins JL, Cohn M. Transformed cell lines susceptible or resistant to in vivo surveillance against tumorigenesis. Nature 276: 510–511, 1978.
14. Saharinen P, Eklund L, Pulkki K, Bono P, Alitalo K. VEGF and angiopoietin signaling in tumor angiogenesis and metastasis. Trends Mol Med 17: 347–362, 2011.
15. Schlegel A, Lesurtel M, Melloul E, Limani P, Tschuor C, Graf R, Humar B, Clavien PA. ALPPS: from human to mice highlighting accelerated and novel mechanisms of liver regeneration. Ann Surg 260: 839–846, 2014.
16. Thalheimer A, Otto C, Bueter M, Illert B, Gattenlohner S, Gasser M, Fein M, Germer CT, Waaga-Gasser AM. Tumor cell dissemination in a human colon cancer animal model: orthotopic implantation or intraportal injection? Eur Surg Res 42: 195–200, 2009.
17. Van Cutsem E, Cervantes A, Nordlinger B, Arnold D, Group EGW. Metastatic colorectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-updagger. Ann Oncol 25: iii1–iii9, 2014.
18. Zhang Z, Zhang F, Lu Y, Zheng S. Update on implications and mechanisms of angiogenesis in liver fibrosis. Hepatol Res 45: 162–178, 2015.